Clinical Trial: Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT03922308) titled 'Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)' on April 5.

Brief Summary: The purpose of this study is to evaluate the pharmacokinetics, safety, and efficacy of rADAMTS-13 (SHP655) administered in addition to standard of care (SoC) treatment of acquired thrombotic thrombocytopenic purpura (aTTP) participants.

Study Type: Interventional

Condition: Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Intervention: * Other: Placebo

Participants will receive injection of placebo matched to SHP655.

* Drug: SHP655

Participants will receive injection of SHP655. ...